Perioperative Renal Outcome in Cardiac Surgical Patients With Preoperative Renal Dysfunction: Aprotinin Versus Epsilon Aminocaproic Acid

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 22, Issue 1, 2008, Pages 6-15

  Maslow, Andrew D ^a   Chaudrey, Alyas ^a   Bert, Arthur ^a   Schwartz, Carl ^a   Singh, Arun ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

aprotinin; cardiopulmonary bypass; creatinine; creatinine clearance; epsilon aminocaproic acid; hemodialysis

Indexed keywords

AMINOCAPROIC ACID; APROTININ; CREATININE;

ADULT; AGED; ANESTHESIST; ARTICLE; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DATA BASE; DIABETES MELLITUS; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART SURGERY; HEMODIALYSIS; HOSPITALIZATION; HUMAN; HYPERTENSION; INTENSIVE CARE UNIT; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICAL RECORD REVIEW; MORTALITY; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; SURGEON; UNIVERSITY HOSPITAL;

6-AMINOCAPROIC ACID; AGED; AGED, 80 AND OVER; ANTIFIBRINOLYTIC AGENTS; APROTININ; CARDIAC SURGICAL PROCEDURES; CREATININE; FEMALE; HEMOSTATICS; HUMANS; INTRAOPERATIVE COMPLICATIONS; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURGICAL PROCEDURES, ELECTIVE; TIME FACTORS; TREATMENT OUTCOME;

EID: 38749128347     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2007.07.017     Document Type: Article

References (48)

1. Loef B.G., Epema A.H., Smilde T.D., et al. Immediate postoperative renal function deterioration in cardiac surgical patients predicts in-hospital mortality and long-term survival. J Am Soc Nephrol 16 (2005) 195-200
2. Lytle B.W., Loop F.D., Cosgrove D.M., et al. Fifteen hundred coronary reoperations: Results and determinants of early and late survival. J Thorac Cardiovasc Surg 93 (1987) 847-859
3. Dacey L.J., Munoz J.J., Baribeau Y.R., et al., Northern New England Cardiovascular Disease Study Group. Reexploration for hemorrhage following coronary artery bypass grafting. Arch Surg 133 (1998) 442-447
4. Zanardo G., Michielon P., Paccagnella A., et al. Acute renal failure in the patient undergoing cardiac operation. Prevalence, mortality rate, and main risk factors. J Thorac Cardiovasc Surg 107 (1994) 1489-1495
5. Chertow G.M., Lazarus J.M., Christiansen C.L., et al. Preoperative renal risk stratification. Circulation 95 (1997) 878-884
6. Bucerius J., Gummert J.F., Borger M.A., et al. Stroke after cardiac surgery: A risk factor analysis of 16,184 consecutive adult patients. Ann Thorac Surg 75 (2003) 472-478
7. Stallwood M.I., Grayson A.D., Mills K., et al. Acute renal failure in coronary artery bypass surgery: Independent effect of cardiopulmonary bypass. Ann Thorac Surg 77 (2004) 968-972
8. Bovre T., Calabro M.G., Landoni G., et al. The incidence and risk of acute renal failure after cardiac surgery. J Cardiothorac Vasc Anesth 18 (2004) 442-445
9. Wijeysundera D.N., Karkouti K., Beattie W.S., et al. Improving the identification of patients at risk of postoperative renal failure after cardiac surgery. Anesthesiology 104 (2006) 65-72
10. Provenchere S., Plantefeve G., Hufnagel G., et al. Renal dysfunction after cardiac surgery with normothermic cardiopulmonary bypass: Incidence, risk factors, and effect on clinical outcome. Anesth Analg 96 (2003) 1258-1264
11. Mora-Mangano C., Diamondstone L.S., Ramsay J.G., et al. Renal dysfunction after myocardial revascularization: Risk factors, adverse outcome, and hospital resource utilization. Ann Intern Med 128 (1998) 194-203
12. Mangano D.T., Tudor I.C., Dietzel C., and Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation. The risk associated with aprotinin in cardiac surgery. N Engl J Med 354 (2006) 353-365
13. Anderson R.J., O'Brien M., Mawhinney S., et al. Renal failure predisposes patients to adverse outcome after coronary artery bypass surgery. Kidney Int 55 (1999) 1057-1062
14. Nakayama Y., Sakata R., Ura M., et al. Long-term results of coronary artery bypass grafting in patients with renal insufficiency. AnnThorac Surg 75 (2003) 496-500
15. Weerasinghe A., Hornick P., Smith P., et al. Coronary artery bypass grafting in nondialysis-dependent mild-to-moderate renal dysfunction. J Thorac Cardiovasc Surg 121 (2001) 1083-1089
16. Penta de Peppo A., Nardi P., De Paulis R., et al. Cardiac surgery in moderate-to-end-stage renal failure: Analysis of risk factors. Ann Thorac Surg 74 (2002) 378-383
17. Durmaz L., Buket S., Atay Y., et al. Cardiac surgery with cardiopulmonary bypass in patients with chronic renal failure. J Thorac Cardiovasc Surg 118 (1999) 306-315
18. Durmaz I., Yagdi T., Calkavur T., et al. Prophylactic dialysis in patients with renal dysfunction undergoing on-pump coronary artery bypass surgery. Ann Thorac Surg 75 (2003) 859-864
19. Cosgrove D.M., Heric B., Lytle B.W., et al. Aprotinin therapy for reoperative myocardial revascularization: A placebo-controlled study. Ann Thorac Surg 54 (1992) 1031-1036
20. Karkouti K., Beattie W.S., Dattilo K.M., et al. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery. Transfusion 46 (2006) 327-338
21. Singh A.K., Feng W.C., Bert A.A., et al. Warm body, cold heart surgery. Clinical experience in 2817 patients. Eur J Cardiothorac Surg 7 (1993) 225-230
22. Bert A.A., Stearns G.T., Feng W., et al. Normothermic cardiopulmonary bypass. J Cardiothorac Vasc Anesth 11 (1997) 91-99
23. Thakar C.V., Arrigain S., Worley S., et al. A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol 16 (2005) 162-168
24. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-44
25. Chertow G.M., Levy E.M., Hammermeister K.E., et al. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 104 (1998) 343-348
26. Holzmann M.J., Ahnve S., Hammar N., et al. Creatinine clearance and risk of early mortality in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 130 (2005) 746-752
27. Asimakopoulos G., Karagounis P., Valencia O., et al. Renal function after cardiac surgery off- versus on-pump coronary artery bypass: Analysis using the Cockroft-Gault formula for estimating creatinine clearance. Ann Thorac Surg 79 (2005) 2024-2031
28. Grayson A.D., Khater M., Jackson M., et al. Valvular heart operation is an independent risk factor for acute renal failure. Ann Thorac Surg 75 (2003) 1829-1835
29. Kuitunen A., Vento A., Suojaranta-Ylinen R., et al. Acute renal failure after cardiac surgery: Evaluation of the RIFLE classification. Ann Thoracic Surg 81 (2006) 542-546
30. Corwin H.L., Sprague S.M., Delaria G.A., et al. Acute renal failure associated with cardiac operations. J Thorac Cardiovasc Surg 98 (1989) 1101-1112
31. Chukwuemeka A., Weisel A., Maganti M., et al. Renal dysfunction in high-risk patients after on-pump and off-pump coronary artery bypass surgery: A propensity score analysis. Ann Thorac Surg 80 (2005) 2148-2154
32. Body S.C., and Mazer C.D. Pro: Aprotinin has a good efficacy and safety profile relative to other alternatives for prevention of bleeding in cardiac surgery. Anesth Analg 103 (2006) 1354-1359
33. Beattie W.S., and Karkouti K. Con: Aprotinin has a good efficacy and safety profile relative to other alternatives for prevention of bleeding in cardiac surgery. Anesth Analg 103 (2006) 1360-1364
34. Maier M., Starlinger M., Zhegu Z., et al. Effects of the protease inhibitor aprotinin on renal hemodynamics in the pig. Hypertension 7 (1985) 32-38
35. D'Ambra M.N., Akins C.W., Blackstone E.H., et al. Aprotinin in primary valve replacement and reconstruction: A multicenter double-blind, placebo-controlled trial. J Thorac Cardiovasc Surg 112 (1996) 1081-1089
36. Kher A., Meldrum K.K., Hile K.L., et al. Aprotinin improves kidney function and decreases tubular cell apoptosis and proapoptotic signaling after renal ischemia-perfusion. J Thorac Cardiovasc Surg 130 (2005) 662-669
37. Schweizer A., Hohn L., Morel D.R., et al. Aprotinin does not impair renal haemodynamics and function after cardiac surgery. Br J Anaesth 84 (2000) 16-22
38. Sedrakyan A., Treasure T., and Elefteriades J.A. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: A systematic review and meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg 128 (2004) 442-448
39. Perazella M.A., and Biswas P. Acute hyperkalemia associated with intravenous epsilon-aminocaproic acid therapy. Am J Kidney Dis 33 (1999) 782-785
40. Biswas C.K., Milligan D.A., Agte S.D., et al. Acute renal failure and myopathy after treatment with aminocaproic acid. Br Med J 281 (1980) 115-116
41. Cooksey M.W., and Knapp M.S. Aminocaproic acid and proteinuria. Br Med J 1 (1968) 769
42. Royston D. High-dose aprotinin therapy: A review of the first five years' experience. J Cardiothorac Vasc Anesth 6 (1992) 76-100
43. Eaton M.P., and Deeb G. Aprotinin versus epsilon-aminocaproic acid for aortic surgery using deep hypothermic circulatory arrest. J Cardthorac Vasc Anesth 12 (1998) 548-552
44. Gaudino M., Luciani N., Giungi S., et al. Different profiles of patients who require dialysis after cardiac surgery. Ann Thorac Surg 79 (2005) 825-830
45. Stafford-Smith, Phillips-Bute B., Reddan D.N., et al. The association of E-aminocaproic acid with postoperative decrease in creatinine clearance in 1502 coronary bypass patients. Anesth Analg 91 (2000) 1085-1090
46. Lemmer J.H., Stanford W., Bonney S.L., et al. Aprotinin for coronary artery bypass grafting: Effect on postoperative renal function. Ann Thorac Surg 59 (1995) 132-136
47. Bidstrup B.P., Harrison J., Royston D., et al. Aprotinin therapy in cardiac operations: A report on use in 41 cardiac centers in the United Kingdom. Ann Thorac Surg 55 (1993) 971-976
48. Mangano D.T., Miao Y., Vuylsteke A., et al. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA 297 (2007) 471-479